Belatacept: is there BENEFIT for liver transplantation too?
Publication
, Other
Knechtle, SJ; Adams, AB
Published in: Am J Transplant
August 2014
The results of the multicenter belatacept liver transplant trial disappoint with respect to safety and efficacy, and new approaches will be required before this agent plays a role in liver transplant immunosuppression. See article by Klintmalm et al on page 1817.
Duke Scholars
Published In
Am J Transplant
DOI
EISSN
1600-6143
Publication Date
August 2014
Volume
14
Issue
8
Start / End Page
1717 / 1718
Location
United States
Related Subject Headings
- Surgery
- Male
- Liver Transplantation
- Immunosuppressive Agents
- Immunoconjugates
- Humans
- Female
- Abatacept
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Knechtle, S. J., & Adams, A. B. (2014). Belatacept: is there BENEFIT for liver transplantation too? Am J Transplant. United States. https://doi.org/10.1111/ajt.12806
Knechtle, S. J., and A. B. Adams. “Belatacept: is there BENEFIT for liver transplantation too?” Am J Transplant, August 2014. https://doi.org/10.1111/ajt.12806.
Knechtle SJ, Adams AB. Belatacept: is there BENEFIT for liver transplantation too? Vol. 14, Am J Transplant. 2014. p. 1717–8.
Knechtle, S. J., and A. B. Adams. “Belatacept: is there BENEFIT for liver transplantation too?” Am J Transplant, vol. 14, no. 8, Aug. 2014, pp. 1717–18. Pubmed, doi:10.1111/ajt.12806.
Knechtle SJ, Adams AB. Belatacept: is there BENEFIT for liver transplantation too? Am J Transplant. 2014. p. 1717–1718.
Published In
Am J Transplant
DOI
EISSN
1600-6143
Publication Date
August 2014
Volume
14
Issue
8
Start / End Page
1717 / 1718
Location
United States
Related Subject Headings
- Surgery
- Male
- Liver Transplantation
- Immunosuppressive Agents
- Immunoconjugates
- Humans
- Female
- Abatacept
- 3204 Immunology
- 3202 Clinical sciences